No recent analyst price targets found for KLYG.
Latest News for KLYG
Kelyniam Global Announces Q2 2026 Financial Results
CANTON, CT / ACCESS Newswire / August 11, 2026 / Kelyniam Global (OTCID:KLYG), a leader in custom cranial implants, today reported its financial results for the six months ended June 30, 2026. The company delivered excellent performance, with strong revenue growth and a clear improvement in profitability.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for KLYG.
U.S. House Trading
No House trades found for KLYG.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.